These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7757234)

  • 1. Isolation of the C3 complement component and its C3d subunit from IY-1 fraction of Cohn's fractionation of human plasma.
    Matveevskaya NS; Alyoshkin VA; Rozina MN
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):261-6. PubMed ID: 7757234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and use of the C3d subunit C3.
    Moore JA; Michael JM; Chaplin H
    Transfusion; 1976; 16(3):200-8. PubMed ID: 1084603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration.
    Stegmayr B; Tärnvik A
    Blood Purif; 1989; 7(1):10-5. PubMed ID: 2784057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the third component of canine complement.
    Johnson JP; Hammer CH; Winkelstein JA
    Vet Immunol Immunopathol; 1985 Apr; 8(4):377-89. PubMed ID: 4002610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.
    Mollnes TE
    Scand J Immunol; 1985 Jun; 21(6):607-13. PubMed ID: 3895396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC; Jensenius JC; Svehag SE; Brandslund I
    J Clin Lab Immunol; 1983 Dec; 12(4):201-8. PubMed ID: 6198522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of C3 level on the determination of C3d in plasma and synovial fluid by radial immunodiffusion.
    Hack CE; Paardekooper J; Hannema AJ
    J Immunol Methods; 1986 Feb; 86(2):191-8. PubMed ID: 3080529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.
    Bourke BE; Moss IK; Maini RN
    J Immunol Methods; 1982; 48(1):97-108. PubMed ID: 6799579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of the third component of bovine complement.
    Menger M; Aston WP
    Vet Immunol Immunopathol; 1985 Dec; 10(4):317-31. PubMed ID: 3832572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of porcine C3. Studies of the biologically active protein and its split products.
    Storm KE; Arturson G; Nilsson UR
    Vet Immunol Immunopathol; 1992 Oct; 34(1-2):47-61. PubMed ID: 1441229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the third component of rat complement.
    Daha MR; Stuffers-Heiman M; Kijlstra A; van Es LA
    Immunology; 1979 Jan; 36(1):63-70. PubMed ID: 422228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.
    Teisner B; Hau J; Svehag SE; Brandslund I; Bøg-Hansen TC
    J Immunol Methods; 1984 Jan; 66(1):113-8. PubMed ID: 6607289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved three-step method for the purification of the third component of human complement.
    Davrinche C; Rivat C; Rivat-Peran L
    J Immunol Methods; 1980; 35(3-4):353-9. PubMed ID: 7400589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of the porcine complement activation fragments C3c and C3d and their use in the preparation of monospecific antibodies.
    Storm KE; Nilsson UR
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):231-41. PubMed ID: 8236800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3c.
    Mlynek Y; Nilsson M
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):195-8. PubMed ID: 3936336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma C3d/C3 quotient as a parameter for in vivo complement activation.
    Nürnberger W; Bhakdi S
    J Immunol Methods; 1984 Nov; 74(1):87-91. PubMed ID: 6334115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human complement factors C3, C5 and H.
    Lundwall A; Eggertsen G
    J Immunol Methods; 1985 Jul; 81(1):147-60. PubMed ID: 3160789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid FPLC method for purification of the third component of human and guinea pig complement.
    Basta M; Hammer CH
    J Immunol Methods; 1991 Aug; 142(1):39-44. PubMed ID: 1919020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.